• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

ARVO calls for applications for Dr. David L. Epstein Award

Article

At its 2017 general business meeting in May, the Association for Research in Vision and Ophthalmology (ARVO) welcomed a new president, Claude F. Burgoyne, MD, FARVO. Dr. Burgoyne, a glaucoma clinician and surgeon, is senior scientist, Van Buskirk Chair for Ophthalmic Research, and director of the Optic Nerve Head Research Laboratory at Devers Eye Institute, Portland, OR. He also serves as clinical professor of ophthalmology at Oregon Health and Sciences University, Eugene.

ARVO View

At its 2017 general business meeting in May, the Association for Research in Vision and Ophthalmology (ARVO) welcomed a new president, Claude F. Burgoyne, MD, FARVO.

Dr. Burgoyne, a glaucoma clinician and surgeon, is senior scientist, Van Buskirk Chair for Ophthalmic Research, and director of the Optic Nerve Head Research Laboratory at Devers Eye Institute, Portland, OR. He also serves as clinical professor of ophthalmology at Oregon Health and Sciences University, Eugene.

ARVO also welcomed Sarah E. Coupland, MBBS, PhD, FARVO (University of Liverpool) as its new vice president and Justine Smith, MBBS, PhD, FARVO (Flinders University) as its new executive vice president.

Steven J. Fliesler, PhD, FARVO (State University of New York-Buffalo) was named president-elect and will serve the 2018-2019 term. Raymond A. Applegate, OD, PhD, FARVO (University of Houston) and Andrew D. Dick, MBBS, MD, FMedSci, FARVO (University of Bristol-Bristol Eye Hospital) are vice presidents-elect for that term.

Other results include the election of three new trustees to the board: T. Michael Redmond, PhD, FARVO (National Eye Institute, National Institutes of Health) will represent the Biochemistry/Molecular Biology (BI) Section; Maureen Maguire, PhD, FARVO (University of Pennsylvania) will represent the Clinical/Epidemiologic Research (CL) Section; and Maureen McCall, PhD, FARVO (University of Louisville) will represent the Visual Neuroscience (VN) section.

2017 ARVO recordings

Miss a presentation at the ARVO 2017 annual meeting? Select sessions--including lectures, mini-symposia, paper sessions, symposia, and workshops--are now available online. All recorded sessions are searchable by session type, related Scientific Section, or Cross-sectional Groups. The ARVO/Alcon Closing Keynote: “What’s next in the investigation of genetics of age-related macular degeneration” is available to the public. An ARVO member login is required to access the remaining recorded sessions (http://arvo.org/Conferences_and_Courses/Meeting_presentations/#AM17).

New online education

 

New online education

As part of its Research Essentials online education training, ARVO is offering two new courses (http://arvo.org/Conferences_and_Courses/Research_essentials) that will help clinician-scientists, ophthalmologists, and ophthalmology residents enhance their research knowledge and skills:

  • Big Data: Current status and future directions

This course defines big data and describes big data sets derived from clinical data available in eye and vision research. Presenters also discuss ways to visualize big data and applications of machine learning.

  • Demystifying statistics and research for ophthalmic investigators

This course focuses on understanding statistical fundamentals and the correct interpretation of ophthalmic data, including examples of “what not to do.”

These online modules were developed from ARVO Education Courses in Baltimore in May. Both offer a series of audio presentations synchronized with slides, and are available at a reduced rate to those who attended the live course ($29) and ARVO members ($149).

Call for applications

The ARVO Foundation is accepting applications for the $100,000 Dr. David L. Epstein Award. This award honors the memory of its namesake, a longtime leader in glaucoma treatment and research. It is given annually to a well-established, senior-level investigator with a documented history of conducting eye and vision research in glaucoma and mentoring clinician-scientists to independent research in academic careers.

Past recipients include David Huang MD, PhD, FARVO, of Oregon Health and Science University and Jonathan G. Crowston, MBBS, FRCOphth, FRANZCO, PhD, of the University of Melbourne and the Centre for Eye Research Australia.

Applications will be accepted through Sept. 1, 11:59 p.m. U.S. Eastern. Go to arvo.org/EpsteinAward-Application_Review to learn more about the criteria and eligibility.

Upcoming ARVO events

 

Upcoming ARVO events

August 8 (Lima, Peru)

  • ARVO@PAAO From Research to Practice: Management of Diabetic Retinopathy

ARVO and the Pan-American Association of Ophthalmology (PAAO) will hold a joint one-day conference, ARVO@PAAO, which aims to bring basic and translational research to PAAO’s clinical environment during the Pan-American Congress of Ophthalmology. Go to http://arvo.org/ARVO@PAAO to learn more and register.

April 29 to May 3, 2018 (Honolulu)

  • ARVO 2018 annual meeting Stand strong for science: Stand for strong vision science

 

 

Katrina Norfleet is director of communications with the Association for Research in Vision and Ophthalmology. Readers may contact her at 240/221-2924 or knorfleet@arvo.org.

 

 

Related Videos
© 2024 MJH Life Sciences

All rights reserved.